NervGen Pharma Announces Results of Annual General Meeting of Shareholders

          NervGen Pharma Announces Results of Annual General Meeting of ShareholdersJune 05, 2024 8:30 AM EDT | Source: NervGen Pharma Corp.All resolutions submitted for approval were passed by shareholdersGlenn Ives appointed as Chair of the BoardJohn Ruffolo appointed as Chair of the Audit CommitteeVancouver, British Columbia--(Newsfile Corp. - June 5, 2024) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF), a clinical-stage biotech company dedicated to developing innovative solutions for the treatme ...